SynthesisCardiovascular and interventional radiology2026
Safety and Efficacy of Absorbable Biliary Stents for Benign Bile Duct Strictures: A Systematic Review and Meta-Analysis.
Synthesis in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Added Procedural Value of Percutaneous Cholangioscopy During Endobiliary Radiofrequency Ablation for a Resistant Benign Hepaticojejunostomy Stricture.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to assess the safety and clinical outcomes of novel biodegradable biliary stents (BDBS) in the treatment of benign biliary strictures (BBS). MATERIALS AND
methodsA systematic literature search on BDBS placement for BBS was conducted in Medline. Studies reporting technical success, clinical success, and BBS recurrence rates were included. A meta-analysis of proportions was used to determine each of the outcomes.
resultsTwelve studies involving 384 patients who underwent 387 BDBS placement for BBS were included. The weighted pooled proportion of technical success was 100% (95% CI 92-100%). After a mean follow-up of 23.3 months, the weight average clinical success was 81% (95% CI 76-85%) and stricture recurrence was 20% (95% CI 14-27%). The mean time to relapse was 11.8 months. Stent migration, complication, and readmission rate were 3% (95% CI 2-6%), 11% (95% CI 5-22%), and 2% (95% CI 0-100%), respectively. No mortality was reported.
conclusionBDBS placement is safe and effective treatment for BBS, with high technical and clinical success with acceptable complication and migration rates. LEVEL OF EVIDENCE: Level 3.
Indexed as
Identifiers
41457173What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.